Netflix, Adobe OK $25B Buybacks; Blackstone Backs Teva

robot
Abstract generation in progress

Netflix and Adobe have each authorized new $25 billion share repurchase programs, with Netflix’s plan having no expiration and Adobe’s running through 2030. While Netflix’s buyback is seen as offensive, Adobe’s comes as the company faces AI disruption fears, leading to a muted market reaction. In contrast, Blackstone Life Sciences is investing up to $400 million in Teva Pharmaceuticals for its duvakitug development, showcasing a growth-focused partnership instead of capital return.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin